Xconomy -- Seattle-based medical device developer NeuroVista has raised $16.5 million in equity financing led by Australian firm GBS Venture Partners, and an additional $5 million through a convertible debt agreement with Houston, TX-based Cyberonics (NASDAQ: CYBX), a medical device firm specializing in the treatment of epilepsy and other neurological disorders.
